All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Oxime antidotes for reactivation of cholinesterases inhibited by highly poisonous organophosphates (REACT)

Public support

  • Provider

    Czech Science Foundation

  • Programme

  • Call for proposals

  • Main participants

    Univerzita Hradec Králové / Přírodovědecká fakulta

  • Contest type

    M2 - International cooperation

  • Contract ID

    26-20584K

Alternative language

  • Project name in Czech

    Oxime antidotes for reactivation of cholinesterases inhibited by highly poisonous organophosphates (REACT)

  • Annotation in Czech

    The highly toxic organophosphorus compounds were used during serious incidents in the last decade. These agents are causing life endangering intoxication that are usually treated by combination of antidotes, where only reactivators (oximes) are able to split organophosphates from cholinesterase active site and restore their physiologic activity. However, the standard oximes were found ineffective antidotes for such highly toxic organophosphorus compounds. For these reasons, the current research is based on searching for oximes with increased reactivation for the specific organophosphates. Thus, this project is focused on proof of concept of increased organophosphate reactivation and organism protection using double charged pyridinium oximes, which will be designed, prepared and thoroughly evaluated for these purposes.

Scientific branches

  • R&D category

    ZV - Basic research

  • OECD FORD - main branch

    30107 - Medicinal chemistry

  • OECD FORD - secondary branch

    30108 - Toxicology

  • OECD FORD - another secondary branch

    30104 - Pharmacology and pharmacy

  • CEP - equivalent branches <br>(according to the <a href="http://www.vyzkum.cz/storage/att/E6EF7938F0E854BAE520AC119FB22E8D/Prevodnik_oboru_Frascati.pdf">converter</a>)

    FP - Other medical fields<br>FR - Pharmacology and apothecary chemistry

Solution timeline

  • Realization period - beginning

    Jan 1, 2026

  • Realization period - end

    Dec 31, 2028

  • Project status

    Z - Beginning multi-year project

  • Latest support payment

Data delivery to CEP

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

  • Data delivery code

    CEP26-GA0-GF-R

  • Data delivery date

    May 23, 2026

Finance

  • Total approved costs

    7,251 thou. CZK

  • Public financial support

    7,251 thou. CZK

  • Other public sources

    0 thou. CZK

  • Non public and foreign sources

    0 thou. CZK